BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6974264)

  • 1. The secondary cytotoxic response to allogeneic cells: the specificity of secondary cytotoxic effectors differs from that of primary effectors.
    Taniguchi K; Nomoto K; Kubo C; Nanishi F
    Jpn J Exp Med; 1981 Apr; 51(2):89-95. PubMed ID: 6974264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cytotoxic lymphocyte responses in vitro by alloantigen-activated spleen cells.
    Truitt GA; Rich RR; Rich SS
    J Immunol; 1977 Jul; 119(1):31-7. PubMed ID: 874322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them.
    Fink PJ; Rammensee HG; Bevan MJ
    J Immunol; 1984 Oct; 133(4):1775-81. PubMed ID: 6332132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses.
    Lucas CJ; Levy RB; Shearer GM
    J Immunol; 1981 Apr; 126(4):1255-9. PubMed ID: 6970767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of carrageenan on the induction of cell-mediated cytotoxic responses in vivo.
    Sakemi T; Kuroiwa A; Nomoto K
    Immunology; 1980 Oct; 41(2):297-302. PubMed ID: 6969217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociated and reconstituted subcellular alloantigen capable of stimulating mouse cytotoxic T lymphocytes in vitro.
    Fast LD; Fan DP
    J Immunol; 1978 Apr; 120(4):1092-6. PubMed ID: 76659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young F mice spontaneously generate cytotoxic T cells against parental targets.
    Ishikawa H; Dutton RW
    J Immunol; 1979 Nov; 123(5):2034-9. PubMed ID: 314956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.
    Gooding LR; Edwards CB
    J Immunol; 1980 Mar; 124(3):1258-62. PubMed ID: 6244348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The induction of alloreactive cytotoxic responses in vivo are inhibited by pretreatment with M is-disparate cells.
    Hayes RL; Claman HN
    J Immunol; 1982 Jul; 129(1):232-5. PubMed ID: 6806359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of recognition of modified-self by alloantigen-activated cytotoxic T lymphocytes.
    Ballas ZK
    J Immunol; 1981 Oct; 127(4):1589-91. PubMed ID: 6168697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of neuraminidase and galactose oxidase on murine lymphocytes. I. Evidence for the differential delivery of signal(s) leading to cell proliferation and the differentiation of cytotoxic T cells.
    Kuppers RC; Henney CS
    J Immunol; 1977 Dec; 119(6):2163-71. PubMed ID: 303259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype.
    Sabapathy TK; Cheng Q; Hui KM
    Cell Immunol; 1995 Nov; 166(1):141-53. PubMed ID: 7585974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response.
    Ishikawa T; Kakumu S; Yoshioka K; Yamada M; Tanaka K; Higashi Y; Takayanagi M; Okumura A; Kojima A; Tamura T
    Immunology; 1993 Oct; 80(2):313-8. PubMed ID: 8262560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on T cell clonal expansion. I. Suppression of killer T cell production in vivo.
    Kamat R; Henney CS
    J Immunol; 1975 Dec; 115(6):1592-8. PubMed ID: 810513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. III. Epidermal cell-specific cytotoxic T lymphocytes.
    Tyler JD; Steinmuller D
    J Immunol; 1981 May; 126(5):1759-63. PubMed ID: 7012238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR
    J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro growth of murine T cells. II. Growth of in vitro sensitized cells cytotoxic for alloantigens.
    Rosenberg SA; Schwarz S; Spiess PJ
    J Immunol; 1978 Nov; 121(5):1951-5. PubMed ID: 309485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tumor-lymphocyte interaction in vitro. VI. Specificity of primary and secondary autologous lymphocyte-mediated cytotoxicity.
    Vánky FT; Vose BM; Fopp M; Klein E
    J Natl Cancer Inst; 1979 Jun; 62(6):1407-13. PubMed ID: 86634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.